• Loading stock data...
September 8, 2020 in Press Release, Top News

CTT Enters into Business Development Partnership with 3 Rivers Biotech

Partnership Further Advances Aggressive Business Development Strategy Pre-eminent Tissue Culture Company Provides Access to Substantial Network of CPG Companies  3 Rivers’ Technology Transfer Capabilities Expand CTT’s Operational Capacity Hamilton, Ontario,…
Read More
Our Vision

VISION

Improve the overall quality of life for patients by providing safe, flexible, simple and innovative drug delivery systems for pain management therapies and treatments.

Our overall mandate is to develop fast dissolving oral thin film wafers of opioids and medical marijuana for treatment of chronic pain, post operative surgical pain, arthritis and joint pain.

Most fast dissolving systems on the market today deliver anti-inflammatories, antihistamines and cough and breath related medications. CTT believes that its technology could gain widespread use in major markets such as Pain Management (MedWafe), Medicinal Marijuana (Cannawafe), as well as Veterinary Medicine (VetWafe).

How it Works